These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21401612)

  • 41. [Acute encephalopathy].
    Tabarki B; Thabet F
    Arch Pediatr; 2012 Aug; 19(8):847, 876-7. PubMed ID: 22749489
    [No Abstract]   [Full Text] [Related]  

  • 42. Biochemical effects of some newer salicylic acid congeners.
    Seth PK; Tangri KK
    J Pharm Pharmacol; 1966 Dec; 18(12):831-3. PubMed ID: 4381672
    [No Abstract]   [Full Text] [Related]  

  • 43. Biochemical study of the anti-inflammatory activity of and -amyrin acetate.
    Gupta MB; Bhalla TN; Tangri KK; Bhargava KP
    Biochem Pharmacol; 1971 Feb; 20(2):401-5. PubMed ID: 4338361
    [No Abstract]   [Full Text] [Related]  

  • 44. Probiotics: a potential target for the prevention and treatment of steatohepatitis.
    Nardone G; Rocco A
    J Clin Gastroenterol; 2004 Jul; 38(6 Suppl):S121-2. PubMed ID: 15220676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Challenging the rodent hegemony: a new rabbit model of nonalcoholic steatohepatitis.
    Behari J; Chalasani N
    Am J Pathol; 2010 Jul; 177(1):10-2. PubMed ID: 20489152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correction to: Bahabadi M, et al., Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease.
    Immunopharmacol Immunotoxicol; 2017 Oct; 39(5):x. PubMed ID: 28691883
    [No Abstract]   [Full Text] [Related]  

  • 47. RETRACTED: Effects of geniposide on hepatocytes undergoing epithelial-mesenchymal transition in hepatic fibrosis by targeting TGFβ/Smad and ERK-MAPK signaling pathways.
    Park JH; Yoon J; Lee KY; Park B
    Biochimie; 2015 Jun; 113():26-34. PubMed ID: 25818617
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose-related liver injury of Geniposide associated with the alteration in bile acid synthesis and transportation.
    Tian J; Zhu J; Yi Y; Li C; Zhang Y; Zhao Y; Pan C; Xiang S; Li X; Li G; Newman JW; Feng X; Liu J; Han J; Wang L; Gao Y; La Frano MR; Liang A
    Sci Rep; 2017 Aug; 7(1):8938. PubMed ID: 28827769
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Geniposidic acid protected against ANIT-induced hepatotoxity and acute intrahepatic cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2.
    Chen H; Huang X; Min J; Li W; Zhang R; Zhao W; Liu C; Yi L; Mi S; Wang N; Wang Q; Zhu C
    J Ethnopharmacol; 2016 Feb; 179():197-207. PubMed ID: 26723467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Geniposide alleviates non-alcohol fatty liver disease via regulating Nrf2/AMPK/mTOR signalling pathways.
    Shen B; Feng H; Cheng J; Li Z; Jin M; Zhao L; Wang Q; Qin H; Liu G
    J Cell Mol Med; 2020 May; 24(9):5097-5108. PubMed ID: 32293113
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Geniposide and Chlorogenic Acid Combination Ameliorates Non-alcoholic Steatohepatitis Involving the Protection on the Gut Barrier Function in Mouse Induced by High-Fat Diet.
    Peng JH; Leng J; Tian HJ; Yang T; Fang Y; Feng Q; Zhao Y; Hu YY
    Front Pharmacol; 2018; 9():1399. PubMed ID: 30618733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolomics analyses reveal the liver-protective mechanism of Wang's metabolic formula on metabolic-associated fatty liver disease.
    Chen S; Huang J; Huang Y; Zhou C; Wang N; Zhang L; Zhang Z; Li B; He X; Wang K; Zhi Y; Lv G; Shen S
    Heliyon; 2024 Jul; 10(13):e33418. PubMed ID: 39040343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction.
    LeFort KR; Rungratanawanich W; Song BJ
    Cell Mol Life Sci; 2024 Jan; 81(1):34. PubMed ID: 38214802
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Terpenoids: Natural Compounds for Non-Alcoholic Fatty Liver Disease (NAFLD) Therapy.
    Yao P; Liu Y
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615471
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Beneficial Effects of Geniposide on Glucose and Lipid Metabolism: A Review.
    Gao S; Feng Q
    Drug Des Devel Ther; 2022; 16():3365-3383. PubMed ID: 36213380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gardeniae Fructus Attenuates Thioacetamide-Induced Liver Fibrosis in Mice via Both AMPK/SIRT1/NF-κB Pathway and Nrf2 Signaling.
    Shin MR; Lee JA; Kim M; Lee S; Oh M; Moon J; Nam JW; Choi H; Mun YJ; Roh SS
    Antioxidants (Basel); 2021 Nov; 10(11):. PubMed ID: 34829709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Impact of Anthocyanins and Iridoids on Transcription Factors Crucial for Lipid and Cholesterol Homeostasis.
    Danielewski M; Matuszewska A; Szeląg A; Sozański T
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disease Status-Dependent Drug-Herb Interactions: NASH Lowered the Risk of Hepatotoxicity in Rats Coadministered With Simvastatin and
    Li Z; Lyu Y; Zhao J; Li D; Lin Z; To KKW; Yan X; Zuo Z
    Front Pharmacol; 2021; 12():622040. PubMed ID: 33967756
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diverse Pharmacological Activities and Potential Medicinal Benefits of Geniposide.
    Zhou YX; Zhang RQ; Rahman K; Cao ZX; Zhang H; Peng C
    Evid Based Complement Alternat Med; 2019; 2019():4925682. PubMed ID: 31118959
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antioxidative Property and Molecular Mechanisms Underlying Geniposide-Mediated Therapeutic Effects in Diabetes Mellitus and Cardiovascular Disease.
    Li N; Li L; Wu H; Zhou H
    Oxid Med Cell Longev; 2019; 2019():7480512. PubMed ID: 31089416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.